Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

OBJECTIVE: To carry out cost-effectiveness analysis from the Spanish National Health System perspective, of treating overactive bladder (OAB), in newly diagnosed patients with two flexible doses of fesoterodine in routine clinical practice. PATIENTS AND METHODS: Economic evaluation of flexible-dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Peral, Carmen, Sánchez-Ballester, Francisco, García-Mediero, José M, Ramos, Jaime, Rejas, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044989/
https://www.ncbi.nlm.nih.gov/pubmed/27713646
http://dx.doi.org/10.2147/CEOR.S111646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044989/
https://www.ncbi.nlm.nih.gov/pubmed/27713646
http://dx.doi.org/10.2147/CEOR.S111646

Ejemplares similares